Variability of plasma drug concentrations: Some observations
Letter To The Editors
Received:
- 14 Downloads
- 2 Citations
Keywords
Drug Concentration Plasma Drug Plasma Drug Concentration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Dayer P, Balant L, Küpfer F, Courvoisier F, Fabre J (1983) Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents. Eur J Clin Pharmacol 24: 797–799Google Scholar
- 2.Idle JR, Sever PS (1983) Treatment of angina pectoris with nifedipine. Br Med J 286: 1978–1979Google Scholar
- 3.Idle JR, Oates NS, Shah RR, Smith RL (1983) Protecting poor metabolisers, a group at high risk of adverse drug reactions. Lancet 1: 1388Google Scholar
- 4.Jack DB, Quarterman CP, Zaman R, Kendall MJ (1982) Variability of beta-blocker pharmacokinetics in young volunteers. Eur J Clin Pharmacol 23: 37–42Google Scholar
- 5.Jack DB, Wilkins MR, Quarterman CP (1983) Lack of evidence for polymorphism in metoprolol metabolism. Br J Clin Pharmacol 16: 188–190Google Scholar
- 6.Lennard MS, Silas JH, Freestone S, Ramsay LE, Tucker GT, Woods HF (1982) Oxidation phenotype — a major determinant of metoprolol metabolism and response. N Engl J Med 307: 1558–1560Google Scholar
- 7.Lennard MS, Ramsay LE, Silas JH, Tucker GT, Woods HF (1983) Protecting the poor metaboliser: Clinical consequences of genetic polymorphism of drug oxidation. Pharm Int 4: 53–57Google Scholar
Copyright information
© Springer-Verlag 1983